ID   HROC183 T0 M2
AC   CVCL_1D17
SY   HROC183X
DR   CLS; 300810
DR   Wikidata; Q54895250
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NMRI nu/nu mice.
CC   Doubling time: 29 hours (CLS=300810).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): CLS=300810
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D16 ! HROC183
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 14
//
RX   PubMed=31601052; DOI=10.3390/cancers11101520; PMCID=PMC6826890;
RA   Mullins, Christina Susanne
RA   Micheel, Bianca
RA   Matschos, Stephanie
RA   Leuchter, Matthias
RA   Burtin, Florian
RA   Krohn, Mathias
RA   Huhns, Maja
RA   Klar, Ernst
RA   Prall, Friedrich
RA   Linnebacher, Michael
RT   "Integrated biobanking and tumor model establishment of human
RT   colorectal carcinoma provides excellent tools for preclinical
RT   research.";
RL   Cancers (Basel) 11:1520.1-1520.18(2019).
//